Biocon Q2 FY26 revenue rises 20% to ₹4,296 crore, driven by biosimilars growth

Biocon Ltd reported Q2 FY26 revenue of ₹4,296 crore, up nearly 20% YoY, led by strong biosimilars performance and improving margins across global markets.

Leave a Reply

Your email address will not be published. Required fields are marked *